Share Name Share Symbol Market Type Share ISIN Share Description
Shire Plc LSE:SHP London Ordinary Share JE00B2QKY057 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -20.50p -0.44% 4,600.50p 4,572.00p 4,574.00p 4,650.00p 4,532.00p 4,626.00p 2,583,216,316 11:32:45
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 11,224.6 3,149.2 348.7 12.5 41,845.33

Shire plc Shire Plc : Elections For The Interim Dividend In Respect Of The Six Months To December 31, 2017

12/03/2018 4:00pm

Dow Jones News

Shire (LSE:SHP)
Historical Stock Chart

1 Year : From Nov 2017 to Nov 2018

Click Here for more Shire Charts.
   Elections for the interim dividend in respect of the six months to 
December 31, 2017 
   March 12, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") 
announced on February 14, 2018, an interim dividend of 29.79 US cents 
per Ordinary Share payable on April 24, 2018, to shareholders on the 
register of members at the close of business on March 9, 2018. 
   Holders of Ordinary Shares are notified that, in order to receive UK 
sourced dividends via the Company's Income Access Share arrangements 
("IAS Arrangements"), they need to have submitted a valid IAS 
Arrangements election form to the Company's Registrar, Equiniti, by no 
later than 5pm (GMT) on March 23, 2018. 
   Holders of Ordinary Shares are advised that: 
   -- any previous elections made using versions of the IAS Arrangements 
      election form in use prior to February 16, 2016, and any elections deemed 
      to have been made prior to April 28, 2016, are no longer valid; and 
   -- if they do not elect, or have not elected using the newly formatted IAS 
      Arrangements election forms published on or after February 16, 2016, to 
      receive UK sourced dividends via the Company's IAS Arrangements, their 
      dividends will be Irish sourced and therefore incur Irish dividend 
      withholding tax, subject to applicable exemptions. 
   Internet links to the newly formatted IAS Arrangements election forms 
can be found at: 
   For further information concerning the IAS Arrangements, please contact 
Equiniti (+44 (0) 121 415 7593). If you are in any doubt as to what 
action to take, please consult your tax advisor immediately. 
   Sarah Rixon 
   Company Secretarial Assistant 
   For further information please contact: 
Investor Relations 
Christoph Brackmann    +41 795 432 359 
Sun Kim                     +1 617 588 8175 
Robert Coates               +44 203 549 0874 
Katie Joyce                  +1 781 482 2779 
   About Shire 
   Shire is the global leader in serving patients with rare diseases. We 
strive to develop best-in-class therapies across a core of rare disease 
areas including hematology, immunology, genetic diseases, neuroscience, 
and internal medicine with growing therapeutic areas in ophthalmics and 
oncology. Our diversified capabilities enable us to reach patients in 
more than 100 countries who are struggling to live their lives to the 
   We feel a strong sense of urgency to address unmet medical needs and 
work tirelessly to improve people's lives with medicines that have a 
meaningful impact on patients and all who support them on their journey.  
   This announcement is distributed by Nasdaq Corporate Solutions on behalf 
of Nasdaq Corporate Solutions clients. 
   The issuer of this announcement warrants that they are solely 
responsible for the content, accuracy and originality of the information 
contained therein. 
   Source: Shire plc via Globenewswire 

(END) Dow Jones Newswires

March 12, 2018 11:45 ET (15:45 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.

1 Year Shire Chart

1 Year Shire Chart

1 Month Shire Chart

1 Month Shire Chart
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V:gb D:20181118 02:21:52